ARTICLE | Clinical News
Endostatin angiogenesis inhibitor regulatory update
February 5, 2001 8:00 AM UTC
Boston Children’s Hospital (Boston, Mass.) received U.S. Patent No. 6,174,861 covering all anti-angiogenic fragments of Endostatin. ENMD is the exclusive licensee of the patent. ...